Welcome to our dedicated page for Leef Brands SEC filings (Ticker: LEEEF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
LEEF Brands Inc. filings document the regulatory record for a California cannabis extraction and manufacturing company with public securities traded under LEEEF. Its S-1/A registration statement amendments describe offering-related disclosures, historical financial statements, property and equipment accounting, share structure and other issuer information tied to its public-company status.
Material-event reports add disclosures on material agreements, shareholder voting matters, governance items, capital-structure changes, security-structure matters, and operating and financial results. For this issuer, the filings center on cannabis operating economics, financing and share activity, and formal corporate actions reported through SEC filings.
Leef Brands, Inc. is seeking U.S. registration for its common shares while operating as a vertically integrated cannabis company focused on bulk concentrates in California and New York. The company runs ethanol, hydrocarbon, and solventless extraction lines and reported 2024 California concentrate sales of $28.5 million, but remains unprofitable with net losses of $24.6 million in 2024 and $34.6 million in 2023.
Leef is building scale through a 1,900‑acre Salisbury Canyon Ranch in Santa Barbara County, targeting up to 187 acres of cultivation that could supply 80–90% of biomass needs and cut input costs by an estimated 40–65%. As of early 2026 it employs about 72 full‑time staff and holds active manufacturing, distribution, retail and processing licenses in California and New York.
The company recently adopted a Bitcoin treasury strategy, allocating a portion of cash reserves to BTC as a long‑term treasury asset held in cold storage and potentially used as collateral. Key risks highlighted include ongoing cash needs, price compression in cannabis markets, heavy tax burdens under U.S. Code Section 280E, limited liquidity and trading volatility in its shares, and extensive federal and state regulatory uncertainty around cannabis legalization and enforcement.
Leef Brands, Inc., a British Columbia-based cannabis extraction and manufacturing company operating in California, has filed an amended prospectus to register shares of common stock for resale by existing security holders. The company will not sell any new shares in this transaction and will receive proceeds only if outstanding warrants are exercised for cash.
Leef positions itself as a vertically integrated cannabis operator, combining large-scale cultivation at its Salisbury Canyon Ranch with high-throughput extraction facilities supplying concentrates to California brands. The business operates in a highly competitive and regulated market and has faced significant price compression, contributing to net losses of $24.6 million in 2024 and $34.6 million in 2023. As of December 22, 2025, 257,947,996 shares of common stock were outstanding. The company highlights substantial risks, including ongoing losses, the need for additional capital, federal illegality of cannabis in the U.S., limited trading liquidity and potentially volatile share prices.
Leef Brands, Inc. filed Amendment No. 1 to a Form S-1 for a resale of common stock by selling security holders. The company is not selling shares in this registration and will not receive proceeds from any resale. The filing states Leef would receive cash only upon the cash exercise of certain Purchase Warrants. Until the stock is listed on an established public market, selling holders may offer shares at a fixed price per share as described in the prospectus.
Leef’s common stock trades on the OTC Pink tier under LEEEF; the last reported price was $0.20 per share on October 24, 2025. The company is an emerging growth and smaller reporting company. Leef operates a vertically integrated cannabis platform in California focused on extraction and B2B concentrates. The company reported a net loss of $24.6 million for the year ended December 31, 2024, and $34.6 million for the year ended December 31, 2023. The prospectus highlights market risks, price compression in California, and capital needs to support growth.